Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Patient Preference Comparison of AZARGA Versus COSOPT
Status: Enrolling
Updated:  5/22/2012
Alcon Call Center
mi
from
Fort Worth, TX
Patient Preference Comparison of AZARGA Versus COSOPT
Status: Enrolling
Updated: 5/22/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Status: Enrolling
Updated:  5/22/2012
Johns Hopkins University
mi
from
Baltimore, MD
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Status: Enrolling
Updated: 5/22/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery
Status: Enrolling
Updated:  5/23/2012
Clinical Research Facility
mi
from
Dallas, TX
A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery
Status: Enrolling
Updated: 5/23/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  5/30/2012
Alcon Call Center
mi
from
Fort Worth, TX
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 5/30/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Travacom Post Marketing Surveillance Study
Post Marketing Surveillance Study to Evaluate the Safety Profile of Travacom (Travoprost/Timolol Fixed Combination) in Patients With Open-Angle Glaucoma or Ocular Hypertension Across India
Status: Enrolling
Updated:  6/1/2012
Alcon Call Center
mi
from
Fort Worth, TX
Travacom Post Marketing Surveillance Study
Post Marketing Surveillance Study to Evaluate the Safety Profile of Travacom (Travoprost/Timolol Fixed Combination) in Patients With Open-Angle Glaucoma or Ocular Hypertension Across India
Status: Enrolling
Updated: 6/1/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
Status: Enrolling
Updated:  6/5/2012
Veterans Affairs Long Beach Healthcare System
mi
from
Long Beach, CA
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
Status: Enrolling
Updated: 6/5/2012
Veterans Affairs Long Beach Healthcare System
mi
from
Long Beach, CA
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Mission Optometry
mi
from
Lake Elsinore, CA
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Mission Optometry
mi
from
Lake Elsinore, CA
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Eyecare Consultants
mi
from
Englewood, CO
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Eyecare Consultants
mi
from
Englewood, CO
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Vision Care Associates
mi
from
East Lansing, MI
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Vision Care Associates
mi
from
East Lansing, MI
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Koetting Associates
mi
from
St. Louis, MO
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Koetting Associates
mi
from
St. Louis, MO
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Visionary Eye Associates
mi
from
Rochester, NY
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Visionary Eye Associates
mi
from
Rochester, NY
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Western Reserve Vision Care
mi
from
Beachwood, OH
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Western Reserve Vision Care
mi
from
Beachwood, OH
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Choate Eye Associates
mi
from
Goodlettsville, TN
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Choate Eye Associates
mi
from
Goodlettsville, TN
Click here to add this to my saved trials
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated:  6/12/2012
Twin Lakes Vision Clinic
mi
from
Federal Way, WA
High Refractive Index Material 510(k)
Prospective Study of Substantial Equivalence of Rigid Gas Permeable HDS HI 1.54™ Daily Wear Lenses for Correction of Naturally Occurring Myopia and Hyperopia From +20 to - 20 D Sphere (Spectacle Plane) With and Without Astigmatism.
Status: Enrolling
Updated: 6/12/2012
Twin Lakes Vision Clinic
mi
from
Federal Way, WA
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Sansum- Santa Barbara medical foundation Clinic
mi
from
Santa Barbara, CA
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Sansum- Santa Barbara medical foundation Clinic
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Katzen Eye Care and Laser Center
mi
from
Boynton Beach, FL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Katzen Eye Care and Laser Center
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated:  6/13/2012
Cleveland Eye Clinic
mi
from
Breckville, OH
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOL
Status: Enrolling
Updated: 6/13/2012
Cleveland Eye Clinic
mi
from
Breckville, OH
Click here to add this to my saved trials
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
Status: Enrolling
Updated:  6/13/2012
Advanced Vision Institute
mi
from
Williamsburg, VA
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
Status: Enrolling
Updated: 6/13/2012
Advanced Vision Institute
mi
from
Williamsburg, VA
Click here to add this to my saved trials
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated:  6/13/2012
Harvard Eye Associates
mi
from
Laguna Hills, CA
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated: 6/13/2012
Harvard Eye Associates
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated:  6/13/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated: 6/13/2012
Center for Excellence in Eye Care
mi
from
Miami, FL
Click here to add this to my saved trials
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated:  6/13/2012
Ophthalmic Consultants of Boston
mi
from
Waltham, MA
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
Status: Enrolling
Updated: 6/13/2012
Ophthalmic Consultants of Boston
mi
from
Waltham, MA
Click here to add this to my saved trials
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Status: Enrolling
Updated:  6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Status: Enrolling
Updated: 6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Click here to add this to my saved trials
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Status: Enrolling
Updated:  6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Status: Enrolling
Updated: 6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Click here to add this to my saved trials
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Status: Enrolling
Updated:  6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Status: Enrolling
Updated: 6/13/2012
University of Nebraska Medical Center, Department of Ophthalmology
mi
from
Omaha, NE
Click here to add this to my saved trials
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Status: Enrolling
Updated:  6/13/2012
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
Status: Enrolling
Updated: 6/13/2012
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Status: Enrolling
Updated:  6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Status: Enrolling
Updated: 6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
Click here to add this to my saved trials
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Status: Enrolling
Updated:  6/13/2012
Koch Eye Associates
mi
from
Warwick, RI
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
A Randomized Masked Evaluation of Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
Status: Enrolling
Updated: 6/13/2012
Koch Eye Associates
mi
from
Warwick, RI
Click here to add this to my saved trials
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Status: Enrolling
Updated:  6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Status: Enrolling
Updated: 6/13/2012
Jackson Eye, S.C
mi
from
Lake Villa, IL
Click here to add this to my saved trials
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Status: Enrolling
Updated:  6/13/2012
Pepose Vision Institute
mi
from
Chesterfield, MO
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
Status: Enrolling
Updated: 6/13/2012
Pepose Vision Institute
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Status: Enrolling
Updated:  6/19/2012
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Status: Enrolling
Updated: 6/19/2012
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability.
Status: Enrolling
Updated:  6/29/2012
Southern California College of Optometry
mi
from
Fullerton, CA
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability.
Status: Enrolling
Updated: 6/29/2012
Southern California College of Optometry
mi
from
Fullerton, CA
Click here to add this to my saved trials
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated:  7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Status: Enrolling
Updated: 7/6/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated:  7/9/2012
Alcon Call Center
mi
from
Fort Worth, TX
A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 7/9/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Prospective Study of Two Daily Disposable Contact Lenses
Status: Enrolling
Updated:  7/10/2012
Alcon Call Center
mi
from
Fort Worth, TX
A Prospective Study of Two Daily Disposable Contact Lenses
Status: Enrolling
Updated: 7/10/2012
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
A Single-Center, Double-Masked, Randomized, Vehicle Controlled Evaluation of the Onset and Duration of Action of RX-10045 Ophthalmic Solution, 0.09% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Status: Enrolling
Updated:  7/12/2012
Andover Eye Associates
mi
from
Andover, MA
Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis
A Single-Center, Double-Masked, Randomized, Vehicle Controlled Evaluation of the Onset and Duration of Action of RX-10045 Ophthalmic Solution, 0.09% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC) Model of Allergic Conjunctivitis
Status: Enrolling
Updated: 7/12/2012
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-patient Study
Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-patient Study
Status: Enrolling
Updated:  7/12/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-patient Study
Topical Lidocaine Gel With and Without Subconjunctival Lidocaine Injection for Intravitreal Injection: a Within-patient Study
Status: Enrolling
Updated: 7/12/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Decatur, GA
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Louisville, KY
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Ashville, NC
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  7/18/2012
Clinical Research Facility
mi
from
Dallas, TX
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 7/18/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
Evaluation of Genetic Variants in Patients Under Treatment for Choroidal Neovascular (CNV) Age-related Macular Degeneration (AMD), Receiving Intravitreal Anti-VEGF Injections (Bevacizumab or Ranibizumab) to Evaluate the Association Between Genetic Load and Response to Therapy/Treatment Burden
Status: Enrolling
Updated:  7/18/2012
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
Evaluation of Genetic Variants in Patients Under Treatment for Choroidal Neovascular (CNV) Age-related Macular Degeneration (AMD), Receiving Intravitreal Anti-VEGF Injections (Bevacizumab or Ranibizumab) to Evaluate the Association Between Genetic Load and Response to Therapy/Treatment Burden
Status: Enrolling
Updated: 7/18/2012
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Open-Angle Glaucoma
Status: Enrolling
Updated:  7/18/2012
Wills Eye Institute
mi
from
Philadelphia, PA
Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Open-Angle Glaucoma
Status: Enrolling
Updated: 7/18/2012
Wills Eye Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  7/19/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 7/19/2012
Retina Vitreous Associates of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  7/19/2012
Retina Vitreous Associates of Florida
mi
from
St. Petersburg, FL
Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 7/19/2012
Retina Vitreous Associates of Florida
mi
from
St. Petersburg, FL
Click here to add this to my saved trials